Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Dermatitis » Drug Eruptions
Diseases [C] » Immune System Diseases [C20] » Hypersensitivity » Drug Hypersensitivity » Drug Eruptions
Diseases [C] » Chemically-Induced Disorders [C25] » Drug-Related Side Effects and Adverse Reactions » Drug Hypersensitivity » Drug Eruptions
Description
Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. MeSH
Hierarchy View
Subtype Terms (7)
Acute Generalized Exanthematous Pustulosis
3 approved drugs
Drug Hypersensitivity Syndrome
9 drugs (8 approved, 1 experimental)
Hand-Foot Syndrome
6 drugs (4 approved, 2 experimental)
Serum Sickness
3 approved drugs
Stevens-Johnson Syndrome
16 drugs (14 approved, 2 experimental)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
